Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-27

Clinical Trial Update: Remission From Stage D Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update from the University of Louisville reports remission in heart failure patients classified as NYHA Class III and IV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Louisville | Conditions: Heart Failure NYHA Class III, Heart Failure NYHA Class IV | Phase 4 | Status: UNKNOWN